Aggarwal, B. B., Banerjee, S., Bharadwaj, U., Sung, B., Shishodia, S., & Sethi, G.
(2007). Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem Pharmacol, 73(7), 1024-1032.
Aggarwal, B. B., Sundaram, C., Malani, N., & Ichikawa, H. (2007). Curcumin: the Indian solid gold. Adv Exp Med Biol, 595, 1-75.
Aggarwal, S., Ichikawa, H., Takada, Y., Sandur, S. K., Shishodia, S., & Aggarwal, B.
B. (2006). Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through
suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol, 69(1), 195-206.
Alcindor, T., & Beauger, N. (2011). Oxaliplatin: a review in the era of molecularly targeted therapy. Curr Oncol, 18(1), 18-25.
Andre, T., Boni, C., Navarro, M., Tabernero, J., Hickish, T., Topham, C., et al. (2009).
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol, 27(19), 3109-3116.
Anto, R. J., Mukhopadhyay, A., Denning, K., & Aggarwal, B. B. (2002). Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis, 23(1), 143-150.
Ashkenazi, A., & Dixit, V. M. (1998). Death receptors: signaling and modulation.
Azuine, M. A., Kayal, J. J., & Bhide, S. V. (1992). Protective role of aqueous turmeric extract against mutagenicity of direct-acting carcinogens as well as benzo [alpha] pyrene-induced genotoxicity and carcinogenicity. J Cancer Res Clin Oncol, 118(6), 447-452.
A comparison of laparoscopically assisted and open colectomy for colon cancer.
(2004). N Engl J Med, 350(20), 2050-2059.
Baldwin, A. S. (2001). Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest, 107(3), 241-246.
Baliga, B. C., Colussi, P. A., Read, S. H., Dias, M. M., Jans, D. A., & Kumar, S.
(2003). Role of prodomain in importin-mediated nuclear localization and activation of caspase-2. The Journal of biological chemistry, 278(7), 4899-4905.
Belakavadi, M., & Salimath, B. P. (2005). Mechanism of inhibition of ascites tumor growth in mice by curcumin is mediated by NF-kB and caspase activated DNase. Mol Cell Biochem, 273(1-2), 57-67.
Biswal, B. M., Sain, A. H., Othman, N. H., & Baba, A. (2002). Adjuvant treatment in colorectal cancer. Experience from a referral center in eastern peninsular Malaysia. Trop Gastroenterol, 23(3), 134-137.
Blommaert, F. A., van Dijk-Knijnenburg, H. C., Dijt, F. J., den Engelse, L., Baan, R.
A., Berends, F., et al. (1995). Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells. [Comparative Study Research Support, Non-U.S. Gov't]. Biochemistry, 34(26), 8474-8480.
Bodmer, J. L., Holler, N., Reynard, S., Vinciguerra, P., Schneider, P., Juo, P., et al.
[Research Support, Non-U.S. Gov't]. Nature cell biology, 2(4), 241-243.
Bonzon, C., Bouchier-Hayes, L., Pagliari, L. J., Green, D. R., & Newmeyer, D. D.
(2006). Caspase-2-induced apoptosis requires bid cleavage: a physiological role for bid in heat shock-induced death. Mol Biol Cell, 17(5), 2150-2157.
Braakhuis, B. J., Snijders, P. J., Keune, W. J., Meijer, C. J., Ruijter-Schippers, H. J., Leemans, C. R., et al. (2004). Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. Journal of the National Cancer Institute, 96(13), 998-1006.
Brabec, V., & Kasparkova, J. (2005). Modifications of DNA by platinum complexes.
Relation to resistance of tumors to platinum antitumor drugs. Drug Resist Updat, 8(3), 131-146.
Briassouli, P., Chan, F., Savage, K., Reis-Filho, J. S., & Linardopoulos, S. (2007).
Aurora-A regulation of nuclear factor-kappaB signaling by phosphorylation of IkappaBalpha. Cancer Res, 67(4), 1689-1695.
Bucher, N., & Britten, C. D. (2008). G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer. Br J Cancer, 98(3), 523-528.
Burlacu, A. (2003). Regulation of apoptosis by Bcl-2 family proteins. Journal of cellular and molecular medicine, 7(3), 249-257.
Burnett-Hartman, A. N., Newcomb, P. A., & Potter, J. D. (2008). Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. [Review]. Cancer epidemiology, biomarkers
& prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 17(11),
2970-2979.
Calvert, A. H., Harland, S. J., Newell, D. R., Siddik, Z. H., Jones, A. C., McElwain, T.
J., et al. (1982). Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol, 9(3), 140-147.
Campbell, F. C., & Collett, G. P. (2005). Chemopreventive properties of curcumin.
Future Oncol, 1(3), 405-414.
Carrington, P. E., Sandu, C., Wei, Y., Hill, J. M., Morisawa, G., Huang, T., et al.
(2006). The structure of FADD and its mode of interaction with procaspase-8.
[Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.]. Molecular cell, 22(5), 599-610.
Casellas, F., Borruel, N., Papo, M., Guarner, F., Antolin, M., Videla, S., et al. (1998).
Antiinflammatory effects of enterically coated amoxicillin-clavulanic acid in active ulcerative colitis. Inflamm Bowel Dis, 4(1), 1-5.
Chang, D. W., Xing, Z., Pan, Y., Algeciras-Schimnich, A., Barnhart, B. C., Yaish-Ohad, S., et al. (2002). c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. The EMBO journal, 21(14), 3704-3714.
Chauhan, D. P. (2002). Chemotherapeutic potential of curcumin for colorectal cancer.
Curr Pharm Des, 8(19), 1695-1706.
Cheah, Y. H., Nordin, F. J., Sarip, R., Tee, T. T., Azimahtol, H. L., Sirat, H. M., et al.
(2009). Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231. Cancer Cell Int, 9, 1.
Chen, A., Xu, J., & Johnson, A. C. (2006). Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor
25(2), 278-287.
Cheng, A. L., Hsu, C. H., Lin, J. K., Hsu, M. M., Ho, Y. F., Shen, T. S., et al. (2001).
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res, 21(4B), 2895-2900.
Christian, C. K., Kwaan, M. R., Betensky, R. A., Breen, E. M., Zinner, M. J., &
Bleday, R. (2005). Risk factors for perineal wound complications following abdominoperineal resection. Dis Colon Rectum, 48(1), 43-48.
Collett, G. P., Robson, C. N., Mathers, J. C., & Campbell, F. C. (2001). Curcumin modifies Apc(min) apoptosis resistance and inhibits 2-amino
1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumour formation in Apc(min) mice. Carcinogenesis, 22(5), 821-825.
Corredoira, J. C., Alonso, M. P., Garcia, J. F., Casariego, E., Coira, A., Rodriguez, A., et al. (2005). Clinical characteristics and significance of Streptococcus
salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study. [Research Support, Non-U.S. Gov't]. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 24(4), 250-255.
Crighton, D., Wilkinson, S., O'Prey, J., Syed, N., Smith, P., Harrison, P. R., et al.
(2006). DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell, 126(1), 121-134.
Cvitkovic, E. (1998). Ongoing and unsaid on oxaliplatin: the hope. British journal of cancer, 77 Suppl 4, 8-11.
Das, A., Chak, A., & Cooper, G. S. (2006). Temporal trend in relative risk of second primary colorectal cancer. Am J Gastroenterol, 101(6), 1342-1347.
Das, P., Skibber, J. M., Rodriguez-Bigas, M. A., Feig, B. W., Chang, G. J., Hoff, P.
M., et al. (2006). Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol, 29(3), 219-224.
De Duve, C. (1963). The lysosome. Sci Am, 208, 64-72.
De Duve, C., & Wattiaux, R. (1966). Functions of lysosomes. Annu Rev Physiol, 28, 435-492.
Debatin, K. M. (2004). Apoptosis pathways in cancer and cancer therapy. [Review].
Cancer immunology, immunotherapy : CII, 53(3), 153-159.
Degterev, A., Boyce, M., & Yuan, J. (2003). A decade of caspases. Oncogene, 22(53), 8543-8567.
Delaunoit, T., Limburg, P. J., Goldberg, R. M., Lymp, J. F., & Loftus, E. V., Jr.
(2006). Colorectal cancer prognosis among patients with inflammatory bowel disease. [Research Support, Non-U.S. Gov't]. Clinical gastroenterology and hepatology : the official clinical practice journal of the American
Gastroenterological Association, 4(3), 335-342.
Demchenko, Y. N., Glebov, O. K., Zingone, A., Keats, J. J., Bergsagel, P. L., &
Kuehl, W. M. (2010). Classical and/or alternative NF-kappaB pathway activation in multiple myeloma. Blood, 115(17), 3541-3552.
Dempe, J. S., Pfeiffer, E., Grimm, A. S., & Metzler, M. (2008). Metabolism of
curcumin and induction of mitotic catastrophe in human cancer cells. Mol Nutr Food Res, 52(9), 1074-1081.
Deveraux, Q. L., & Reed, J. C. (1999). IAP family proteins--suppressors of apoptosis.
Genes Dev, 13(3), 239-252.
Dhillon, N., Aggarwal, B. B., Newman, R. A., Wolff, R. A., Kunnumakkara, A. B.,
advanced pancreatic cancer. Clin Cancer Res, 14(14), 4491-4499.
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000). Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. Cell, 102(1), 33-42.
du Plessis-Stoman, D., du Preez, J., & van de Venter, M. (2011). Combination treatment with oxaliplatin and mangiferin causes increased apoptosis and downregulation of NFkappaB in cancer cell lines. Afr J Tradit Complement Altern Med, 8(2), 177-184.
Duarte, V. M., Han, E., Veena, M. S., Salvado, A., Suh, J. D., Liang, L. J., et al.
(2010). Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKKbeta protein of the NFkappaB pathway. Mol Cancer Ther, 9(10), 2665-2675.
Dunn, W. A., Jr. (1990). Studies on the mechanisms of autophagy: formation of the autophagic vacuole. J Cell Biol, 110(6), 1923-1933.
Eastman, A. (2004). Cell cycle checkpoints and their impact on anticancer therapeutic strategies. J Cell Biochem, 91(2), 223-231.
Epstein, J., Docena, G., MacDonald, T. T., & Sanderson, I. R. (2010). Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease. Br J Nutr, 103(6), 824-832.
Erdman, S. E., & Poutahidis, T. (2010a). Cancer inflammation and regulatory T cells.
[Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review]. International journal of cancer. Journal international du cancer, 127(4), 768-779.
Erdman, S. E., & Poutahidis, T. (2010b). Roles for inflammation and regulatory T cells in colon cancer. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review].
Toxicologic pathology, 38(1), 76-87.
Fengsrud, M., Roos, N., Berg, T., Liou, W., Slot, J. W., & Seglen, P. O. (1995).
Ultrastructural and immunocytochemical characterization of autophagic vacuoles in isolated hepatocytes: effects of vinblastine and asparagine on vacuole distributions. Exp Cell Res, 221(2), 504-519.
Ferguson, A. M., White, L. S., Donovan, P. J., & Piwnica-Worms, H. (2005). Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases. Mol Cell Biol, 25(7), 2853-2860.
Fowler, P. J., Grous, M., Price, W., & Matthews, W. D. (1984). Pharmacological differentiation of postsynaptic alpha adrenoceptors in the dog saphenous vein.
J Pharmacol Exp Ther, 229(3), 712-718.
Furuta, S., Hidaka, E., Ogata, A., Yokota, S., & Kamata, T. (2004). Ras is involved in the negative control of autophagy through the class I PI3-kinase. Oncogene, 23(22), 3898-3904.
Furuya, N., Yu, J., Byfield, M., Pattingre, S., & Levine, B. (2005). The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy, 1(1), 46-52.
Garcia-Aguilar, J., Pollack, J., Lee, S. H., Hernandez de Anda, E., Mellgren, A., Wong, W. D., et al. (2002). Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum, 45(1), 10-15.
Ghavami, S., Asoodeh, A., Klonisch, T., Halayko, A. J., Kadkhoda, K., Kroczak, T. J.,
mechanism, which involves the lysosomal-mitochondrial death pathway.
[Research Support, Non-U.S. Gov't]. Journal of cellular and molecular medicine, 12(3), 1005-1022.
Ghavami, S., Eshraghi, M., Kadkhoda, K., Mutawe, M. M., Maddika, S., Bay, G. H., et al. (2009). Role of BNIP3 in TNF-induced cell death--TNF upregulates BNIP3 expression. [Research Support, Non-U.S. Gov't]. Biochimica et biophysica acta, 1793(3), 546-560.
Ghavami, S., Hashemi, M., Ande, S. R., Yeganeh, B., Xiao, W., Eshraghi, M., et al.
(2009). Apoptosis and cancer: mutations within caspase genes. [Research Support, Non-U.S. Gov't Review]. Journal of medical genetics, 46(8), 497-510.
Ghavami, S., Kerkhoff, C., Los, M., Hashemi, M., Sorg, C., & Karami-Tehrani, F.
(2004). Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. [Research Support, Non-U.S. Gov't]. Journal of leukocyte biology, 76(1), 169-175.
Ghobrial, I. M., Witzig, T. E., & Adjei, A. A. (2005). Targeting apoptosis pathways in cancer therapy. [Research Support, Non-U.S. Gov't Review]. CA: a cancer journal for clinicians, 55(3), 178-194.
Ghosh, S., & Karin, M. (2002). Missing pieces in the NF-kappaB puzzle. Cell, 109 Suppl, S81-96.
Giam, M., Huang, D. C., & Bouillet, P. (2008). BH3-only proteins and their roles in programmed cell death. Oncogene, 27 Suppl 1, S128-136.
Giladi, N., Kazanov, D., Shpitz, B., Aroch, I., Kraus, S., & Arber, N. (2010).
Curcumin potentiates the pro-apoptotic effects of sulindac sulfone in colorectal cancer. Expert Opin Investig Drugs, 19 Suppl 1, S117-124.
Gingras, A. C., Raught, B., & Sonenberg, N. (2001). Regulation of translation initiation by FRAP/mTOR. Genes Dev, 15(7), 807-826.
Goel, A., Kunnumakkara, A. B., & Aggarwal, B. B. (2008). Curcumin as
"Curecumin": from kitchen to clinic. Biochem Pharmacol, 75(4), 787-809.
Gonzalez, V. M., Fuertes, M. A., Alonso, C., & Perez, J. M. (2001). Is
cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol, 59(4), 657-663.
Grady, W. M., & Carethers, J. M. (2008). Genomic and epigenetic instability in colorectal cancer pathogenesis. [Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S. Review]. Gastroenterology, 135(4), 1079-1099.
Green, D. R. (2000). Apoptotic pathways: paper wraps stone blunts scissors. Cell, 102(1), 1-4.
Guillou, P. J., Quirke, P., Thorpe, H., Walker, J., Jayne, D. G., Smith, A. M., et al.
(2005). Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet, 365(9472), 1718-1726.
Guo, Y., Srinivasula, S. M., Druilhe, A., Fernandes-Alnemri, T., & Alnemri, E. S.
(2002). Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. The Journal of biological chemistry, 277(16), 13430-13437.
Gupta, S. (2003). Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). International journal of oncology, 22(1), 15-20.
Haller, D. G., Tabernero, J., Maroun, J., de Braud, F., Price, T., Van Cutsem, E., et al.
(2011). Capecitabine plus oxaliplatin compared with fluorouracil and folinic
1465-1471.
Hassan, C., Laghi, A., Zullo, A., Iafrate, F., & Morini, S. (2008). Q&A on diagnosis, screening and follow-up of colorectal neoplasia. Dig Liver Dis, 40(2), 85-96.
Hayden, M. S., & Ghosh, S. (2008). Shared principles in NF-kappaB signaling. Cell, 132(3), 344-362.
He, C., & Levine, B. (2010). The Beclin 1 interactome. Curr Opin Cell Biol, 22(2), 140-149.
Higby, D. J., Wallace, H. J., Jr., Albert, D. J., & Holland, J. F. (1974).
Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors. Cancer, 33(5), 1219-1215.
Hockenbery, D. M. (2010). Targeting mitochondria for cancer therapy. Environ Mol Mutagen, 51(5), 476-489.
Hoetelmans, R. W., Van de Velde, C. J., & Van Dierendonck, J. H. (2003). The presence of 19-kDa Bcl-2 in dividing cells. Cell Prolif, 36(6), 293-306.
Houghton, J., Li, H., Fan, X., Liu, Y., Liu, J. H., Rao, V. P., et al. (2010). Mutations in bone marrow-derived stromal stem cells unmask latent malignancy.
[Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.]. Stem cells and development, 19(8), 1153-1166.
Howells, L. M., Mitra, A., & Manson, M. M. (2007). Comparison of oxaliplatin- and curcumin-mediated antiproliferative effects in colorectal cell lines. Int J Cancer, 121(1), 175-183.
Huang, J., & Klionsky, D. J. (2007). Autophagy and human disease. Cell Cycle, 6(15), 1837-1849.
Huang, X. F., Luo, S. K., Xu, J., Li, J., Xu, D. R., Wang, L. H., et al. (2008). Aurora
kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia. Blood, 111(5), 2854-2865.
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., et al.
(1997). Inhibition of death receptor signals by cellular FLIP. [Research Support, Non-U.S. Gov't]. Nature, 388(6638), 190-195.
Jaattela, M. (2004). Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene, 23(16), 2746-2756.
Jiang, M. C., Yang-Yen, H. F., Lin, J. K., & Yen, J. J. (1996). Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells. Oncogene, 13(3), 609-616.
Johns, L. E., & Houlston, R. S. (2001). A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol, 96(10), 2992-3003.
Johnson, S. M., Gulhati, P., Arrieta, I., Wang, X., Uchida, T., Gao, T., et al. (2009a).
Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Anticancer research, 29(8), 3185-3190.
Johnson, S. M., Gulhati, P., Arrieta, I., Wang, X., Uchida, T., Gao, T., et al. (2009b).
Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling. Anticancer Res, 29(8), 3185-3190.
Joza, N., Susin, S. A., Daugas, E., Stanford, W. L., Cho, S. K., Li, C. Y., et al. (2001).
Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature, 410(6828), 549-554.
Jung, C. H., Ro, S. H., Cao, J., Otto, N. M., & Kim, D. H. (2010). mTOR regulation
Jung, Y., & Lippard, S. J. (2007). Direct cellular responses to platinum-induced DNA damage. Chem Rev, 107(5), 1387-1407.
Kaldis, P., Russo, A. A., Chou, H. S., Pavletich, N. P., & Solomon, M. J. (1998).
Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities. Mol Biol Cell, 9(9), 2545-2560.
Kang, R., Zeh, H. J., Lotze, M. T., & Tang, D. (2011). The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ, 18(4), 571-580.
Kapiteijn, E., Marijnen, C. A., Nagtegaal, I. D., Putter, H., Steup, W. H., Wiggers, T., et al. (2001). Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med, 345(9), 638-646.
Karmakar, S., Banik, N. L., Patel, S. J., & Ray, S. K. (2006). Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for
apoptosis in human glioblastoma T98G cells. Neurosci Lett, 407(1), 53-58.
Kataoka, T., Budd, R. C., Holler, N., Thome, M., Martinon, F., Irmler, M., et al.
(2000). The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. Current biology : CB, 10(11), 640-648.
Keating, J., Pater, P., Lolohea, S., & Wickremesekera, K. (2003). The epidemiology of colorectal cancer: what can we learn from the New Zealand Cancer Registry? N Z Med J, 116(1174), U437.
Kelley, R. K., Wang, G., & Venook, A. P. (2011). Biomarker use in colorectal cancer therapy. J Natl Compr Canc Netw, 9(11), 1293-1302.
Kerr, J. F., Wyllie, A. H., & Currie, A. R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer, 26(4), 239-257.
Kim, J. S., Lee, J. H., Jeong, W. W., Choi, D. H., Cha, H. J., Kim do, H., et al. (2008).
Reactive oxygen species-dependent EndoG release mediates cisplatin-induced caspase-independent apoptosis in human head and neck squamous carcinoma cells. International journal of cancer. Journal international du cancer, 122(3), 672-680.
Kim, R. (2005). Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer, 103(8), 1551-1560.
Kim, R., Inoue, H., & Toge, T. (2004). Bax is an important determinant for radiation sensitivity in esophageal carcinoma cells. International journal of molecular medicine, 14(4), 697-706.
Kim, R., Tanabe, K., Emi, M., Uchida, Y., Inoue, H., & Toge, T. (2003). Inducing cancer cell death by targeting transcription factors. [Review]. Anti-cancer drugs, 14(1), 3-11.
Kim, R., Tanabe, K., Uchida, Y., Emi, M., Inoue, H., & Toge, T. (2002). Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. [Review].
Cancer chemotherapy and pharmacology, 50(5), 343-352.
Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H., et al. (1995). Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. [Research Support, Non-U.S. Gov't]. The EMBO journal, 14(22), 5579-5588.
Kischkel, F. C., Lawrence, D. A., Tinel, A., LeBlanc, H., Virmani, A., Schow, P., et al.
(2001). Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. The Journal of biological chemistry,
Klionsky, D. J. (2007). Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol, 8(11), 931-937.
Kunnumakkara, A. B., Diagaradjane, P., Guha, S., Deorukhkar, A., Shentu, S., Aggarwal, B. B., et al. (2008). Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear
factor-kappaB-regulated gene products. Clin Cancer Res, 14(7), 2128-2136.
Kunnumakkara, A. B., Guha, S., Krishnan, S., Diagaradjane, P., Gelovani, J., &
Aggarwal, B. B. (2007). Curcumin potentiates antitumor activity of
gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear
factor-kappaB-regulated gene products. Cancer Res, 67(8), 3853-3861.
Kvansakul, M., Yang, H., Fairlie, W. D., Czabotar, P. E., Fischer, S. F., Perugini, M.
A., et al. (2008). Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ, 15(10), 1564-1571.
Kwon, Y., & Magnuson, B. A. (2009). Age-related differential responses to
curcumin-induced apoptosis during the initiation of colon cancer in rats. Food Chem Toxicol, 47(2), 377-385.
Lacy, A. M., Garcia-Valdecasas, J. C., Delgado, S., Castells, A., Taura, P., Pique, J.
M., et al. (2002). Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet,
359(9325), 2224-2229.
Layek, R., Datta, A., Bittner, M., & Dougherty, E. R. (2011). Cancer therapy design based on pathway logic. Bioinformatics, 27(4), 548-555.
Lee, J., Giordano, S., & Zhang, J. (2012). Autophagy, mitochondria and oxidative
stress: cross-talk and redox signalling. Biochem J, 441(2), 523-540.
Lee, T. L., Yeh, J., Friedman, J., Yan, B., Yang, X., Yeh, N. T., et al. (2008). A signal network involving coactivated NF-kappaB and STAT3 and altered p53
modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas. International journal of cancer. Journal international du cancer, 122(9), 1987-1998.
Lee, Y., Kim, Y. J., Choi, Y. J., Lee, J. W., Lee, S., & Chung, H. W. (2012).
Enhancement of cisplatin cytotoxicity by benzyl isothiocyanate in HL-60 cells.
Food Chem Toxicol, 50(7), 2397-2406.
Lepre, C. A., Strothkamp, K. G., & Lippard, S. J. (1987). Synthesis and 1H NMR spectroscopic characterization of
trans-[Pt(NH3)2[d(ApGpGpCpCpT)-N7-A(1),N7-G(3)]]. [Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.]. Biochemistry, 26(18), 5651-5657.
Li, H., Zhu, H., Xu, C. J., & Yuan, J. (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell, 94(4), 491-501.
Li, J., Vesey, D. A., Johnson, D. W., & Gobe, G. (2007). Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathway. Cancer Biol Ther, 6(12), 1944-1950.
Li, J., & Yuan, J. (2008). Caspases in apoptosis and beyond. [Research Support, N.I.H., Extramural Review]. Oncogene, 27(48), 6194-6206.
Li, L. Y., Luo, X., & Wang, X. (2001). Endonuclease G is an apoptotic DNase when released from mitochondria. Nature, 412(6842), 95-99.
of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis, 23(8), 1307-1313.
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., et al. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. [Research Support, Non-U.S.
Gov't Research Support, U.S. Gov't, P.H.S.]. Cell, 91(4), 479-489.
Li, W., Srinivasula, S. M., Chai, J., Li, P., Wu, J. W., Zhang, Z., et al. (2002).
Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. Nature structural biology, 9(6), 436-441.
Liang, C., & Jung, J. U. (2010). Autophagy genes as tumor suppressors. Curr Opin Cell Biol, 22(2), 226-233.
Lin, S. S., Huang, H. P., Yang, J. S., Wu, J. Y., Hsia, T. C., Lin, C. C., et al. (2008).
DNA damage and endoplasmic reticulum stress mediated curcumin-induced cell cycle arrest and apoptosis in human lung carcinoma A-549 cells through the activation caspases cascade- and mitochondrial-dependent pathway.
Cancer Lett, 272(1), 77-90.
Liu, B., Bai, Q. X., Chen, X. Q., Gao, G. X., & Gu, H. T. (2007). [Effect of curcumin on expression of survivin, Bcl-2 and Bax in human multiple myeloma cell line]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 15(4), 762-766.
Liu, H. S., Ke, C. S., Cheng, H. C., Huang, C. Y., & Su, C. L. (2011).
Curcumin-induced mitotic spindle defect and cell cycle arrest in human bladder cancer cells occurs partly through inhibition of aurora A. Mol Pharmacol, 80(4), 638-646.
Lockshin, R. A., & Zakeri, Z. (2004). Apoptosis, autophagy, and more. Int J Biochem
Cell Biol, 36(12), 2405-2419.
Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., et al. (2002). Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell, 10(3), 457-468.
Lorenzo, H. K., Susin, S. A., Penninger, J., & Kroemer, G. (1999). Apoptosis
inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. [Research Support, Non-U.S. Gov't Review]. Cell death and differentiation, 6(6), 516-524.
Ly, J. D., Grubb, D. R., & Lawen, A. (2003). The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. [Review]. Apoptosis : an international journal on programmed cell death, 8(2), 115-128.
M'Koma, A. E., Moses, H. L., & Adunyah, S. E. (2011). Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences. [Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review]. International journal of colorectal disease, 26(5), 533-552.
Mabuchi, S., Ohmichi, M., Nishio, Y., Hayasaka, T., Kimura, A., Ohta, T., et al.
(2004). Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. The Journal of biological chemistry, 279(22), 23477-23485.
Mackenzie, G. G., Queisser, N., Wolfson, M. L., Fraga, C. G., Adamo, A. M., &
Oteiza, P. I. (2008). Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells. Int J Cancer, 123(1), 56-65.
Martucci, C., et al. (2000). Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis, 21(5),
Martucci, C., et al. (2000). Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis, 21(5),